Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

WNT5A (wingless-type MMTV integration site family, member 5A)

Identity

Other namesWNT-5A
HGNC WNT5A
Location 3p14.3
Location_base_pair Starts at 55474783 and ends at 55496371 bp from pter ( according to hg18-Mar_2006).
Local_order CACNA2D3 - WNT5A - ERC2
Note WNT family ligand. WNT family members with conserved 22 or 24 Cys residues are secreted-type glycoproteins, which are implicated in embryogenesis and carcinogenesis. Nineteen WNT family genes exist within the human genome.

DNA/RNA

Note WNT5A gene at chromosome 3p14.3 and WNT5B gene at chromosome 12p13.33 are paralogs within the human genome.
 
  Schematic representation of WNT5A gene.
Note [Annexed document]
  Alignment of mammalian WNT5A and WNT5B orthologs. N-terminal signal peptide (double over-line), conserved Cys residues (+), and Asn-linked glycosylation sites are shown.
Description WNT5A gene consists of 5 exons. First methionine is located in exon 1, while stop codon in exon 5. dbSNP rs655731, located within exon 5 of the human WNT5A gene, is a synonymous SNP corresponding to codon 263.
Transcription WNT5A is preferentially upregulated in gastric cancer, and melanoma, but downregulated in breast cancer, colorectal cancer, and acute lymphocytic leukemia.
Wnt5a is upregulated by IL6 family cytokines through gp130 in cultured cardiomyocytes, by TGFbeta in mammary epithelial cells, and by TNFalpha in gastric cancer cells. WNT5A upregulation in primary tumor is in part due to stromal expression based on tumor-stromal interaction, while WNT5A downregulation in primary tumor is in part due to epigenetic silencing induced by promoter CpG hypermethylation.

Protein

Description Mature WNT5A protein with conserved Cys residues is a secreted-type glycoprotein.
Expression WNT5A mRNA is relatively abundantly expressed in salivary gland, bladder, uterus, placenta, and fetal kidney.
Localisation Naive WNT5A protein is synthesized in the endoplasmic reticulum. Mature WNT5A protein with lipid modifications and glycosylations enters the trans-Golgi network for secretion from the cell surface.
Function WNT5A signals are transduced to the canonical and non-canonical WNT signaling cascades. WNT5A signaling through Frizzled-4 ( FZD4 ) or FZD5 receptor and LRP5 or LRP6 co-receptor leads to the stabilization and nuclear accumulation of beta-catenin for the transcriptional activation of target genes, such as MYC, CCND1, and FGF20. On the other hand, WNT5A signaling through Frizzled family receptor or ROR1 or ROR2 co-receptor leads to the activation of the non-canonical WNT signaling cascades, such as DAG - PKC, IP3 - NFAT, or IP3 - NLK signaling cascades. WNT5A-PKC signaling promotes invasion and metastasis of tumors through SNAI1 (Snail)-mediated epithelial-to-mesenchymal transition (EMT), while WNT5A-NLK signaling suppresses carcinogenesis through inhibition of the canonical WNT signaling cascade. Expression of WNT5A is associated with metastatic or aggressive phenotype in gastric cancer, melanoma, and osteosarcoma, but is associated with non-aggressive or better prognostic phenotype in breast cancer, colorectal cancer, and acute lymphocytic leukemia. Together these facts indicate that WNT5A induces oncogenic as well as tumor suppressive functions in a context-dependent manner.
Homology Human WNT5A shows 98.7% total amino-acid identity with rodent Wnt5a, indicating that mammalian WNT5A orthologs are highly conserved. Among 19 WNT family members, WNT5A is most homologous to WNT5B.

Mutations

Note WNT5A gene is located at human chromosome 3p14.3 around the susceptible locus of Zimmermann-Laband Syndrome; however, mutation of WNT5A gene has not been detected.
Germinal Wnt5a knockout mice show smaller somites and shortened presomitic mesoderm, abnormalities in the lungs with the foreshortened trachea, dysplasia of genitals, and ventricular septal defects.

Implicated in

Entity Melanoma
Prognosis Poor prognosis
  
Entity Gastric cancer
Prognosis Poor prognosis
  
Entity Osteosarcoma
Prognosis Poor prognosis
  
Entity Breast cancer
Prognosis Better prognosis
  
Entity Colorectal cancer
Prognosis Better prognosis
  
Entity Acute lymphocytic leukemia
Prognosis Better prognosis
  

External links

Nomenclature
HGNCWNT5A   12784
Entrez_GeneWNT5A  7474  wingless-type MMTV integration site family, member 5A
Cards
AtlasWNT5AID42825ch3p14
GeneCardsWNT5A
EnsemblENSG00000114251 [Gene_View]  WNT5A [Vega]
GenatlasWNT5A
Genomic and cartography
GoldenPathWNT5A  -  3p14.3   chr3:55474783-55496371 -  3p21-p14   [Description]    (hg18-Mar_2006)
EnsemblWNT5A - 3p21-p14 [CytoView]
NCBIMapview
OMIM164975 Disease map [OMIM]
HomoloGeneWNT5A
Gene and transcription
GenbankAI634753 [ ENTREZ ]
GenbankAK021503 [ ENTREZ ]
GenbankAK090582 [ ENTREZ ]
GenbankAK290375 [ ENTREZ ]
GenbankAK290869 [ ENTREZ ]
RefSeqNM_003392 [ SRS ]    NM_003392 [ ENTREZ ]
RefSeqAC_000046 [ SRS ]    AC_000046 [ ENTREZ ]
RefSeqAC_000135 [ SRS ]    AC_000135 [ ENTREZ ]
RefSeqNC_000003 [ SRS ]    NC_000003 [ ENTREZ ]
RefSeqNT_022517 [ SRS ]    NT_022517 [ ENTREZ ]
RefSeqNW_001838877 [ SRS ]    NW_001838877 [ ENTREZ ]
RefSeqNW_921651 [ SRS ]    NW_921651 [ ENTREZ ]
CCDSWNT5A CCDS - NCBI
AceViewWNT5A AceView - NCBI
UnigeneHs.696364 [ SRS ]    Hs.696364 [ NCBI ]
Fast-db8589 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtP41221 [ SRS]    P41221 [ EXPASY ]     P41221 [ INTERPRO ]     P41221 [ UNIPROT ] P41221 [ VarSplice FASTA ]
PrositePS00246 WNT1 [ SRS ]    PS00246 WNT1 [ Expasy ]
InterproIPR005816 Wnt_grthfactor [ SRS ]    IPR005816 Wnt_grthfactor [ EBI ]
InterproIPR005817 Wnt_SF [ SRS ]    IPR005817 Wnt_SF [ EBI ]
CluSTrP41221
PfamPF00110 wnt [ SRS ]    PF00110 wnt [ Sanger ]    pfam00110 [ NCBI-CDD ]
SmartSM00097 WNT1 [EMBL]
BlocksP41221
HPRD01293
Protein Interaction databases
DIPP41221
IntActP41221
Polymorphism : SNP, mutations, diseases
OMIM164975    [ map ]   
GENETests164975
SNPWNT5A [dbSNP-NCBI]  
SNPNM_003392 [SNP-NCI]  
SNPWNT5A [GeneSNPs - Utah]  WNT5A] [HGBASE - SRS]
HAPMAPWNT5A [HAPMAP]  
HGMDWNT5A
Genetic AssociationWNT5A
CDC HuGEWNT5A
General knowledge
Family BrowserWNT5A [UCSC Family Browser]
SOURCENM_003392
SMDHs.696364
SAGEHs.696364
GOsignal transducer activity [Amigo]  signal transducer activity
GOreceptor binding [Amigo]  receptor binding
GOextracellular region [Amigo]  extracellular region
GOproteinaceous extracellular matrix [Amigo]  proteinaceous extracellular matrix
GOextracellular space [Amigo]  extracellular space
GOsoluble fraction [Amigo]  soluble fraction
GOsignal transduction [Amigo]  signal transduction
GOWnt receptor signaling pathway, calcium modulating pathway [Amigo]  Wnt receptor signaling pathway, calcium modulating pathway
GOJNK cascade [Amigo]  JNK cascade
GOcell-cell signaling [Amigo]  cell-cell signaling
GOanatomical structure morphogenesis [Amigo]  anatomical structure morphogenesis
GOembryonic development [Amigo]  embryonic development
GOlung development [Amigo]  lung development
GOembryonic limb morphogenesis [Amigo]  embryonic limb morphogenesis
KEGGWnt signaling pathway
KEGGHedgehog signaling pathway
PubGeneWNT5A
TreeFamWNT5A
CTD7474 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeWNT5A Related clones (RZPD - Berlin)
PubMed
PubMed46 Pubmed reference(s) in Entrez

Bibliography

Molecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14-p21.
Clark CC, Cohen I, Eichstetter I, Cannizzaro LA, McPherson JD, Wasmuth JJ, Iozzo RV.
Genomics 1993; 18: 249-260.
PMID 8288227
 
Wnt-5a and Wnt-7a are expressed in the developing chick limb bud in a manner suggesting roles in pattern formation along the proximodistal and dorsoventral axes.
Dealy CN, Roth A, Ferrari D, Brown AM, Kosher RA.
Mech Dev 1993; 43: 175-186.
PMID 8297789
 
Xwnt-5A: a maternal Wnt that affects morphogenetic movements after overexpression in embryos of Xenopus laevis.
Moon RT, Campbell RM, Christian JL, McGrew LL, Shih J, Fraser S.
Development 1993; 119: 97-111.
PMID 8275867
 
Differential transformation of mammary epithelial cells by Wnt genes.
Wong GT, Gavin BJ, McMahon AP.
Mol Cell Biol 1994; 14: 6278-6286.
PMID 8065359
 
Aberrant expression of the growth factor Wnt-5A in human malignancy.
Iozzo RV, Eichstetter I, Danielson KG.
Cancer Res 1995; 55: 3495-3499.
PMID 7627953
 
Wnt5a cloning, expression, and up-regulation in human primary breast cancers.
Lejeune S, Huguet EL, Hamby A, Poulsom R, Harris AL.
Clin Cancer Res 1995; 1: 215-222.
PMID 9815976
 
A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells.
Austin TW, Solar GP, Ziegler FC, Liem L, Matthews W.
Blood 1997; 89: 3624-3635.
PMID 9160667
 
Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma.
Bui TD, Zhang L, Rees MC, Bicknell R, Harris AL.
Br J Cancer 1997; 75: 1131-1136.
PMID 9099960
 
A member of the Frizzled protein family mediating axis induction by Wnt-5A.
He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H.
Science 1997; 275: 1652-1654.
PMID 9054360
 
Modulation of embryonic intracellular Ca2+ signaling by Wnt-5A.
Slusarski DC, Yang-Snyder J, Busa WB, Moon RT.
Dev Biol 1997; 182: 114-120.
PMID 9073455
 
Identification of c-MYC as a target of the APC pathway.
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW.
Science 1998; 281: 1509-1512.
PMID 9727977
 
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O, McCormick F.
Nature 1999; 398: 422-426.
PMID 10201372
 
A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo.
Yamaguchi TP, Bradley A, McMahon AP, Jones S.
Development 1999; 126: 1211-1123.
PMID 10021340
 
Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.
Jonsson M, Dejmek J, Bendahl PO, Andersson T.
Cancer Res 2002; 62: 409-416.
PMID 11809689
 
Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFa in MKN45 cells and up-regulation of WNT5B by beta-estradiol in MCF-7 cells.
Saitoh T, Katoh M.
Int J Mol Med 2002; 10: 345-349.
PMID 12165812
 
Frequent up-regulation of WNT5A mRNA in primary gastric cancer.
Saitoh T, Mine T, Katoh M.
Int J Mol Med 2002; 9: 515-519.
PMID 11956659
 
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM.
Cancer Cell 2002; 1: 279-288.
PMID 12086864
 
Gene-expression profiling in human cutaneous melanoma.
Carr KM, Bittner M, Trent JM.
Oncogene 2003; 22: 3076-3080.
PMID 12789283
 
The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway.
Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Ohkawara B, Koshida I, Suzuki K, Yamada G, Schwabe GC, Mundlos S, Shibuya H, Takada S, Minami Y.
Genes Cells 2003; 8: 645-654.
PMID 12839624
 
Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes.
Fujio Y, Matsuda T, Oshima Y, Maeda M, Mohri T, Ito T, Takatani T, Hirata M, Nakaoka Y, Kimura R, Kishimoto T, Azuma J.
FEBS Lett 2004 Aug; 573: 202-206.
PMID 15327998
 
FGF20 and DKK1 are transcriptional targets of beta-catenin and FGF20 is implicated in cancer and development.
Chamorro MN, Schwartz DR, Vonica A, Brivanlou AH, Cho KR, Varmus HE.
EMBO J 2005; 24: 73-84.
PMID 15592430
 
Expression pattern of Wnt signaling components in the adult intestine.
Gregorieff A, Pinto D, Begthel H, Destrée O, Kielman M, Clevers H.
Gastroenterology 2005; 129: 626-638.
PMID 16083717
 
WNT/PCP signaling pathway and human cancer.
Katoh M.
Oncol Rep 2005; 14: 1583-1588. (Review)
PMID 16273260
 
Comparative genomics on Wnt5a and Wnt5b genes.
Katoh M, Katoh M.
Int J Mol Med 2005; 15: 749-753.
PMID 15754042
 
Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1a signaling in human mammary epithelial cells.
Dejmek J, Säfholm A, Kamp Nielsen C, Andersson T, Leandersson K.
Mol Cell Biol 2006; 26: 6024-6036.
PMID 16880514
 
Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
Mikels AJ, Nusse R.
PLoS Biol 2006; 4: e115.
PMID 16602827
 
Wnt5a signaling is critical for macrophage-induced invasion of breast cancer cell lines.
Pukrop T, Klemm F, Hagemann T, Gradl D, Schulz M, Siemes S, Trumper L, Binder C.
Proc Natl Acad Sci USA 2006; 103: 5454-5459.
PMID 16569699
 
The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, Bittner M, Weeraratna AT.
J Biol Chem 2007; 282:17259-17271.
PMID 17426020
 
STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis, and cancer.
Katoh M, Katoh M.
Int J Mol Med 2007; 19: 273-278. (Review).
PMID 17203201
 
Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth.
Roarty K, Serra R.
Development 2007; 134: 3929-3939.
PMID 17898001
 
Expression of WNT5A and its downstream effector beta-catenin in uveal melanoma.
Zuidervaart W, Pavey S, van Nieuwpoort FA, Packer L, Out C, Maat W, Jager MJ, Gruis NA, Hayward NK.
Melanoma Res 2007; 17: 380-386.
PMID 17992121
 
Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration
Cheng C, Yeh J, Fan T, Smith SK, Charnock-Jones DS.
Biochem Biophys Res Commun 2008; 365: 285-290.
PMID 17986384
 
Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a.
Fukuda T, Chen L, Endo T, Tang L, Lu D, Castro JE, Widhopf GF 2nd, Rassenti LZ, Cantwell MJ, Prussak CE, Carson DA, Kipps TJ.
Proc Natl Acad Sci USA 2008; 105: 3047-3052.
PMID 18287027
 
Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling.
Pilarsky C, Ammerpohl O, Sipos B, Dahl E, Hartmann A, Wellmann A, Braunschweig T, Lohr M, Jesnowski R, Friess H, Wente MN, Kristiansen G, Jahnke B, Denz A, Ruckert F, Schackert HK, Kloppel G, Kalthoff H, Saeger HD, Grutzmann R.
J Cell Mol Med 2008; in press.
PMID 18298655
 
Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors.
Witze ES, Litman ES, Argast GM, Moon RT, Ahn NG.
Science 2008; 320: 365-369.
PMID 18420933
 
WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J, Li H, Yu J, Ng KM, Poon FF, Wong SC, Chan AT, Sung JJ, Tao Q.
Clin Cancer Res 2008; 14: 55-61.
PMID 18172252
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written06-2008Masaru Katoh
Genetics and Cell Biology Section, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan

Citation

This paper should be referenced as such :
Katoh M . WNT5A (wingless-type MMTV integration site family, member 5A). Atlas Genet Cytogenet Oncol Haematol. June 2008 .
URL : http://AtlasGeneticsOncology.org/Genes/WNT5AID42825ch3p14.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Thu Nov 27 13:31:20 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.